US EditionHm Ciocc Treated More than 4,000 New Cancer Patients in 2025 and Administered More than 14,200 Treatments
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
HM Hospitals has reported that the Clara Campal CIOCC Integral Cancer Center attended more than 4,000 new patients in 2025, conducted more than 41,400 oncological consultations and administered more than 14,200 chemotherapy treatments, data that, according to the Group, consolidate a highly complex care model based on personalized medicine, multidisciplinary work and clinical decision-making based on scientific evidence.
The Clara Campal CIOCC Integral Oncological Center, headquartered in Madrid and present in Barcelona, Santiago de Compostela and Malaga, is consolidated as the healthcare reference for private oncology in Spain. In 2025, the center carried out more than 41,400 oncological consultations and administered more than 14,200 chemotherapy treatments, supported by a model of personalized medicine and scientific evidence. Antonio Cubillo, director of HM …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
